The outpatient and interventional psychiatry market is experiencing dynamic shifts in access to care but still suffers from a significant unmet need. The last half decade has seen more Americans seek treatment as well as a proliferation of investment in the space. To drive this growth, players have employed both de novo and inorganic growth strategies to drive scale, expand across the care continuum, and develop market leadership. Companies with profitable business models, that can demonstrate outcomes clinically and show market leadership, will fetch the strongest valuations and market interest – particularly if they can cover the entire acuity spectrum.

Read more about our perspectives on the emerging outpatient and interventional psychiatry market, how to drive operational excellence, benchmark key unit economics, and understand private equity and M&A activity within this burgeoning market: